• Acute rhinosinusitis: the role of mucociliary clearance support (literature review)
en To content Full text of article

Acute rhinosinusitis: the role of mucociliary clearance support (literature review)

Modern Pediatrics. Ukraine. (2026).2(154): 29-34. doi: 10.15574/SP.2026.2(154).2934
Khaitovych M. V., Didkovskiy V. L.
Bogomolets National Medical University, Kyiv, Ukraine

For citation: Khaitovych MV, Didkovskiy VL. (2026). Acute rhinosinusitis: the role of mucociliary clearance support (literature review). Modern Pediatrics. Ukraine. 2(154): 29-34. doi: 10.15574/SP.2026.2(154).2934.
Article received: Jan 05, 2026. Accepted for publication: Mar 16, 2026.

Acute rhinosinusitis (ARS) is one of the most common upper respiratory tract diseases and significantly affects patients’ quality of life. Impairment of mucociliary clearance is a key pathogenic mechanism contributing to pathogen persistence, progression of inflammation, and development of bacterial complications.
Aim – to summarize current evidence on the role of mucociliary clearance in the pathogenesis of ARS and to analyze available approaches for its pharmacological support.
A narrative review of current scientific publications, international guidelines, and consensus documents addressing the etiology, pathogenesis, and treatment of ARS, with particular attention to factors affecting mucociliary transport, was performed. The efficiency of mucociliary clearance depends on the integrity of the ciliated epithelium, ciliary beat frequency, and rheological properties of mucus. Viral and bacterial pathogens may directly damage ciliated cells, alter mucus characteristics, and promote biofilm formation, leading to impaired mucociliary transport. Some intranasal medications, including topical decongestants and corticosteroids, may negatively influence ciliary activity. Current therapeutic strategies focus on restoring mucociliary function through saline irrigation, mucoactive agents, anti-inflammatory therapy, and symptomatic treatment. Oral combination products containing a decongestant and an antihistamine may reduce nasal obstruction without direct contact with the nasal mucosa, improving mucociliary clearance.
Conclusions. Impaired mucociliary clearance plays a crucial role in the development and progression of ARS. Restoration of mucociliary transport promotes pathogen elimination, reduces inflammation, and improves clinical outcomes. Treatment selection should be based on current evidence and consider the effects of medications on mucociliary function.
No conflict of interest was declared by the author.
Keywords: acute rhinosinusitis, mucociliary clearance, ciliated epithelium, nasal obstruction, decongestants, antihistamines.

REFERENCES

1. Anderson TS, Suda KJ, Gellad WF, Tadrous M. (2024, Mar 5). Trends in Phenylephrine and Pseudoephedrine Sales in the US. JAMA. 331(9): 796. https://doi.org/10.1001/jama.2023.27932; PMid:38329748 PMCid:PMC10853864

2. Arcimowicz M. (2024, Oct 1). Rational treatment of acute rhinosinusitis in the context of increasing antibiotic resistance. Otolaryngol Pol. 78(6): 1-11. https://doi.org/10.5604/01.3001.0054.7506; PMid:39540274

3. At Thobari J, Satria CD, Ridora Y, Watts E, Handley A, Standish J et al. (2020, Nov 18_). Non-antibiotic medication use in an Indonesian community cohort 0-18 months of age. Link E, editor. PLOS ONE. 15(11): e0242410. https://doi.org/10.1371/journal.pone.0242410; PMid:33206684 PMCid:PMC7673523

4. Bustamante-Marin XM, Ostrowski LE. (2017, Apr). Cilia and Mucociliary Clearance. Cold Spring Harb Perspect Biol. 9(4): a028241. https://doi.org/10.1101/cshperspect.a028241; PMid:27864314 PMCid:PMC5378048

5. Cantekin EI, Rockette HE, Bluestone CD, Beery QC. (1980, May). Effect of Decongestant with or without Antihistamine on Eustachian Tube Function. Ann Otol Rhinol Laryngol. 89; 3_suppl: 290-295. https://doi.org/10.1177/00034894800890S368; PMid:6778330

6. Chitsuthipakorn W, Hoang MP, Kanjanawasee D, Seresirikachorn K, Snidvongs K. (2022, Dec). Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta‐analyses. Int Forum Allergy Rhinol. 12(12): 1480-1502. https://doi.org/10.1002/alr.23015; PMid:35446512

7. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al. (2020, Feb 1). European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinol J. 58; Suppl S29: 1-464. https://doi.org/10.4193/Rhin20.600; PMid:32077450

8. Graf P. (1999, Oct). Adverse Effects of benzalkonium chloride on the nasal mucosa: Allergic rhinitis and rhinitis medicamentosa. Clin Ther. 21(10): 1749-1755. https://doi.org/10.1016/S0149-2918(99)80053-8; PMid:10566570

9. Grossan M. (2017). Mucociliary Clearance: Measures and Therapies. otolaryngology. 7(6): 336. https://doi.org/10.4172/2161-119X.1000336

10. Guo Z, Martucci NJ, Liu Y, Yoo E, Tako E, Mahler GJ. (2018, May 28). Silicon dioxide nanoparticle exposure affects small intestine function in an in vitro model. Nanotoxicology. 12(5): 485-508. https://doi.org/10.1080/17435390.2018.1463407; PMid:29668341 PMCid:PMC6157813

11. Hatton RC, Hendeles L. (2022, Nov). Why Is Oral Phenylephrine on the Market After Compelling Evidence of Its Ineffectiveness as a Decongestant? Ann Pharmacother. 56(11): 1275-1278. https://doi.org/10.1177/10600280221081526; PMid:35337187

12. Hoffmans R, Wagemakers A, Van Drunen C, Hellings P, Fokkens W. (2018, Feb 5). Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment. Liu Z, editor. PLOS ONE. 13(2): e0192330. https://doi.org/10.1371/journal.pone.0192330; PMid:29401486 PMCid:PMC5798836

13. Huang F, Liu F, Zhen X, Gong S, Chen W, Song Z. (2024, Aug 16). Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis. Microorganisms. 12(8): 1690. https://doi.org/10.3390/microorganisms12081690; PMid:39203531 PMCid:PMC11357447

14. Instruktsiia dlia medychnoho zastosuvannia likarskoho zasobu MILI NOSIK. URL: https://likicontrol.com.ua/%D1%96%D0%BD%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%86%D1%96%D1%8F/?[30577.

15. Jaume F, Quintó L, Alobid I, Mullol J. (2018, Jan). Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 8(1): e018788. https://doi.org/10.1136/bmjopen-2017-018788; PMid:29391364 PMCid:PMC5878244

16. Jiao J, Zhang L. (2019). Influence of Intranasal Drugs on Human Nasal Mucociliary Clearance and Ciliary Beat Frequency. Allergy Asthma Immunol Res. 11(3): 306. https://doi.org/10.4168/aair.2019.11.3.306; PMid:30912321 PMCid:PMC6439188

17. Kim KH, Jun M, Lee MK. (2020, Nov 10). Bioavailability of the Common Cold Medicines in Jellies for Oral Administration. Pharmaceutics. 12(11): 1073. https://doi.org/10.3390/pharmaceutics12111073; PMid:33182644 PMCid:PMC7697653

18. Kua CH, Lee SRE, Cheng SST, Lin JFY, Wang H, Lee GWF. (2021, Oct 18). Evaluating the optimization of the use of sedating antihistamines in a community pharmacy: a retrospective quality improvement study in Singapore. Int J Pharm Pract. 29(5): 451-457. https://doi.org/10.1093/ijpp/riab035; PMid:34244771

19. Kwon E, Hathaway C, Sutton AE. (2026). Acute Sinusitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. URL: http://www.ncbi.nlm.nih.gov/books/NBK547701/ PubMed PMID: 31613481.

20. Livier Castillo J, Flores Valdés JR, Maney Orellana M, Satish S, Ijioma CE, Benjamin J et al. (2023, Nov 19). The Use and Efficacy of Oral Phenylephrine Versus Placebo Treating Nasal Congestion Over the Years on Adults: A Systematic Review. Cureus. 15(11): e49074. https://doi.org/10.7759/cureus.49074; PMid:38125218 PMCid:PMC10730950

21. Modaresi MA, Shirani E. (2022, Jul 21). Effects of continuous and discrete boundary conditions on the movement of upper-convected maxwell and Newtonian mucus layers in coughing and sneezing. Eur Phys J Plus. 137(7): 846. https://doi.org/10.1140/epjp/s13360-022-03067-x; PMid:35892063 PMCid:PMC9302954

22. Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU et al. (2021, Mar). International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 11(3): 213-739. https://doi.org/10.1002/alr.22741; PMid:33236525

23. Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. (2010, Apr 1). Influenza Virus Infection Decreases Tracheal Mucociliary Velocity and Clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 42(4): 450-460. https://doi.org/10.1165/rcmb.2007-0417OC; PMid:19520922 PMCid:PMC2848738

24. Roth D, Şahin AT, Ling F, Tepho N, Senger CN, Quiroz EJ et al. (2025, Mar 12). Structure and function relationships of mucociliary clearance in human and rat airways. Nat Commun. 16(1): 2446. https://doi.org/10.1038/s41467-025-57667-z; PMid:40069153 PMCid:PMC11897160

25. Stjärne P, Odebäck P, Ställberg B, Lundberg J, Olsson P. (2012, Feb). 20High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care. Prim Care Respir J. 21(2): 174-179. https://doi.org/10.4104/pcrj.2012.00011; PMid:22349918 PMCid:PMC6548015

Ural A, Oktemer TK26. , Kizil Y, Ileri F, Uslu S. (2009, May). Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study. J Laryngol Otol. 123(5): 517-721. https://doi.org/10.1017/S0022215108003964; PMid:18957157